Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04740918
What this trial is testing

Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 96
Early research (Phase 1)Looking for participantsNCT04485559
What this trial is testing

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Who this might be right for
Recurrent World Health Organization (WHO) Grade II GliomaLow-grade GliomaHigh-Grade Glioma (HGG)
University of California, San Francisco 50
Testing effectiveness (Phase 2)Study completedNCT00431561
What this trial is testing

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Isarna Therapeutics GmbH 141
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Early research (Phase 1)Study completedNCT01660360
What this trial is testing

Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic Cancer
PharmAbcine 26
Early research (Phase 1)Study completedNCT02926768
What this trial is testing

Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungLung Diseases+1 more
Checkpoint Therapeutics, Inc. 136
Early research (Phase 1)Study completedNCT02914990
What this trial is testing

Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 36
Early research (Phase 1)Study completedNCT02499224
What this trial is testing

Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy

Who this might be right for
Solid Tumors
CellabMED 39
Not applicableEnded earlyNCT00216814
What this trial is testing

Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors

Who this might be right for
Bladder Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 220
Testing effectiveness (Phase 2)Looking for participantsNCT06059690
What this trial is testing

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Who this might be right for
Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00444678
What this trial is testing

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
NYU Langone Health 36
Not applicableStudy completedNCT02293733
What this trial is testing

Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)

Who this might be right for
NSCLC Non Small Cells Lung Cancer
Groupe Francais De Pneumo-Cancerologie 144
Testing effectiveness (Phase 2)WithdrawnNCT04576208
What this trial is testing

Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Takeda
Testing effectiveness (Phase 2)UnknownNCT03126799
What this trial is testing

Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)

Who this might be right for
EGFR Positive Non-small Cell Lung Cancer
National Cancer Center, Korea 128
Not applicableStudy completedNCT02386384
What this trial is testing

TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure

Who this might be right for
InfertilityRecurrent Pregnancy Loss
Eastern Virginia Medical School 15
Testing effectiveness (Phase 2)Study completedNCT02370849
What this trial is testing

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Chinese Academy of Medical Sciences 2
Not applicableNot Yet RecruitingNCT07236723
What this trial is testing

Vitamin D, Nerve Growth Factor and Nerve Conduction Studies in Adult Male Type 2 Diabetic Neuropathy Patients

Who this might be right for
Diabetic Neuropathy
Aswan University 57
Early research (Phase 1)Active Not RecruitingNCT05514496
What this trial is testing

NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer

Who this might be right for
EGFR Mutation-Related Tumors
Nalo Therapeutics Inc. 258
Large-scale testing (Phase 3)Ended earlyNCT04197986
What this trial is testing

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Who this might be right for
Upper Tract Urothelial CarcinomasUrothelial Bladder Cancer
QED Therapeutics, a BridgeBio company 39
Early research (Phase 1)Study completedNCT00001269
What this trial is testing

Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 100
Next Page